On February 28, 2023, the Board of Directors of Graybug Vision, Inc. (Graybug) determined it to be in Graybug's best interests to terminate Parisa Zamiri's employment in advance of the anticipated closing date of the Merger (as defined below), and to provide her the payments to which she is entitled under Graybug's Change in Control Severance Policy (the CIC Severance Policy). In connection with Dr. Zamiri ceasing to serve as Graybug's Chief Medical Officer, Graybug entered into a separation agreement with Dr. Zamiri, dated February 28, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.24 USD | +0.77% | +0.77% | +83.22% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+83.22% | 61M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- CALC Stock
- News CalciMedica, Inc.
- Graybug Vision, Inc. Announces Parisa Zamiri Cease to Serve as Chief Medical Officer